314 related articles for article (PubMed ID: 16411207)
1. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
Pulsipher MA; Nagler A; Iannone R; Nelson RM
Pediatr Blood Cancer; 2006 Apr; 46(4):422-33. PubMed ID: 16411207
[TBL] [Abstract][Full Text] [Related]
2. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
3. Blood stem cell procurement: donor safety issues.
Anderlini P; Przepiorka D; Körbling M; Champlin R
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S35-9. PubMed ID: 9712491
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
[TBL] [Abstract][Full Text] [Related]
5. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
[TBL] [Abstract][Full Text] [Related]
7. Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints.
Heldal D; Brinch L; Tjønnfjord G; Solheim BG; Egeland T; Gadeholt G; Albrechtsen D; Aamodt G; Evensen SA
Bone Marrow Transplant; 2002 Mar; 29(6):479-86. PubMed ID: 11960266
[TBL] [Abstract][Full Text] [Related]
8. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
[TBL] [Abstract][Full Text] [Related]
9. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW
Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366
[TBL] [Abstract][Full Text] [Related]
10. Healthy sibling donation of G-CSF primed stem cells: a call for research.
Pentz RD
Pediatr Blood Cancer; 2006 Apr; 46(4):407-8. PubMed ID: 16395683
[No Abstract] [Full Text] [Related]
11. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003.
Pulsipher MA; Levine JE; Hayashi RJ; Chan KW; Anderson P; Duerst R; Osunkwo I; Fisher V; Horn B; Grupp SA
Bone Marrow Transplant; 2005 Feb; 35(4):361-7. PubMed ID: 15608659
[TBL] [Abstract][Full Text] [Related]
12. [Collection of peripheral hematopoietic stem cells for transplantation from volunteer donors--siblings of the patients].
Mayer J; Korístek Z; Krahulová M; Pospísil Z; Doubek M; Klabusay M; Brychtová Y; Hoffová V; Cernanská J; Krejcí M; Vorlícek J
Vnitr Lek; 2001 Sep; 47 Suppl 1():15-28. PubMed ID: 11693058
[TBL] [Abstract][Full Text] [Related]
13. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation.
Cesaro S; Marson P; Gazzola MV; De Silvestro G; Destro R; Pillon M; Calore E; Messina C; Zanesco L
Haematologica; 2002 Aug; 87(8 Suppl):35-41. PubMed ID: 12412388
[TBL] [Abstract][Full Text] [Related]
14. Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors.
Hilbe W; Nussbaumer W; Bonatti H; Thaler J; Niederwieser D; Nachbaur D
Bone Marrow Transplant; 2000 Oct; 26(7):811-3. PubMed ID: 11042668
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S
Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933
[TBL] [Abstract][Full Text] [Related]
16. Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors.
López-Holgado N; Pata C; Villarón E; Sánchez-Guijo F; Alberca M; Martín A; Corral M; Sánchez-Abarca I; Pérez-Simón JA; San Miguel JF; del Cañizo MC
Haematologica; 2005 Mar; 90(3):353-9. PubMed ID: 15749668
[TBL] [Abstract][Full Text] [Related]
17. Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee.
Grupp SA; Frangoul H; Wall D; Pulsipher MA; Levine JE; Schultz KR
Pediatr Blood Cancer; 2006 Apr; 46(4):414-21. PubMed ID: 16463346
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood stem cell mobilization with granulocyte colony-stimulating factor and a harvesting procedure in pediatric donors.
Kawano Y; Takaue Y; Watanabe T; Watanabe A; Iwai A; Kuroda Y
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S32-4. PubMed ID: 9712490
[TBL] [Abstract][Full Text] [Related]
19. Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study.
Tassi C; Tazzari PL; Bonifazi F; Giudice V; Nannetti A; Ricci F; Rizzi S; Bandini G; Conte R
Bone Marrow Transplant; 2005 Aug; 36(4):289-94. PubMed ID: 15968277
[TBL] [Abstract][Full Text] [Related]
20. Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.
Martino M; Console G; Dattola A; Callea I; Messina G; Moscato T; Massara E; Irrera G; Fedele R; Gervasi A; Bresolin G; Iacopino P
Bone Marrow Transplant; 2009 Aug; 44(3):163-8. PubMed ID: 19182833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
